Clearmind Medicine Inc. (CMND)
NASDAQ: CMND · Real-Time Price · USD
1.650
+0.040 (2.48%)
At close: Aug 12, 2026, 4:00 PM EDT
1.660
+0.010 (0.61%)
After-hours: Aug 12, 2026, 7:36 PM EDT
Clearmind Medicine Market Cap
Clearmind Medicine has a market cap or net worth of $2.45 million as of August 12, 2026. Its market cap has decreased by -52.26% in one year.
Market Cap
2.45M
Enterprise Value
-11.06M
1-Year Change
-52.26%
Ranking
Category
Stock Price
$1.65
ChartMarket Cap Chart
Since August 16, 2021, Clearmind Medicine's market cap has decreased from $26.11M to $2.45M, a decrease of -90.61%. That is a compound annual growth rate of -37.75%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2026 | 2.45M | -9.71% |
| Dec 31, 2025 | 2.71M | -55.12% |
| Dec 31, 2024 | 6.05M | 27.16% |
| Dec 29, 2023 | 4.76M | -39.11% |
| Dec 30, 2022 | 7.81M | -59.09% |
| Dec 27, 2021 | 19.09M | -26.88% |
| Aug 16, 2021 | 26.11M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| 60 Degrees Pharmaceuticals | 2.98M |
| Propanc Biopharma | 2.76M |
| GRI Bio | 2.74M |
| Artelo Biosciences | 2.54M |
| Oragenics | 2.43M |
| Moleculin Biotech | 2.35M |
| Virax Biolabs Group | 2.34M |
| Azitra | 2.28M |